HWHongzheng Wang

Hongzheng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hongzheng Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Hui Hui

    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of -Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, China

    2 shared publications
  • Hui Li

    State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Carcinogenesis and Intervention China Pharmaceutical University Nanjing People's Republic of China

    2 shared publications
  • Mengyuan Zhu

    Department of oncology, the seventh affiliated hospital of Sun Yat-sen University, Shenzhen, Guangdong, 510080, P.R. China

    2 shared publications
  • Po Hu

    School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China

    2 shared publications
  • Qinglong Guo

    School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing Jiangsu China

    2 shared publications
  • Xiangyuan Wang

    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China

    2 shared publications

Latest Publications

  • Identification of the chemical constituents in Cullen corylifolium ethanolic extract by LC-MS/MS and GC-MS

    by Hongzheng Wang, Keyu Chen, Rui Xue, Chimengul Turghun, Bo Han

    Cullen corylifolium has been used to treat bronchial asthma, vitiligo, nephritis and leucopenia from ancient times in China. However, its chemical composition has not been fully understood. In this study, both LC-MS and GC-MS were used to identify the chemical composition in C. corylifolium. Consequently, 31 compounds were qualified by LC-MS/MS, 8 representative compounds of which were quantified, 62 compounds including hydrocarbons, terpenoids and coumarins were identified by GC-MS. Among a total of 93 compounds, 32 compounds (8 by LC-MS/MS and 24 by GC-MS) are undocumented for this herb. Our results will provide a crucial foundation for further studies related to its pharmaceutical activities and quality control. Graphical Abstract


  • Open Access

    One‐Two Punch Therapy for the Treatment of T‐Cell Malignancies Involving p53‐Dependent Cellular Senescence

    by Yingjie Qing, Hui Li, Yunzi Zhao, Po Hu, Xiangyuan Wang, Xiaoxuan Yu, Mengyuan Zhu, Hongzheng Wang, Zhanyu Wang, Qinglong Guo, et al.

    T‐cell malignancies are still difficult to treat due to a paucity of plans that target critical dependencies. Drug‐induced cellular senescence provides a permanent cell cycle arrest during tumorigenesis and cancer development, particularly when combined with senolytics to promote apoptosis of senescent cells, which is an innovation for cancer therapy. Here, our research found that wogonin, a well‐known natural flavonoid compound, not only had a potential to inhibit cell growth and proliferation but also induced cellular senescence in T‐cell malignancies with nonlethal concentration. Transcription activity of senescence‐suppression human telomerase reverse transcriptase (hTERT) and oncogenic C-MYC was suppressed in wogonin‐induced senescent cells, resulting in the inhibition of telomerase activity. We also substantiated the occurrence of DNA damage during the wogonin‐induced aging process. Results showed that wogonin increased the activity of senescence‐associated β‐galactosidase (SA‐β‐Gal) and activated the DNA damage response pathway mediated by p53. In addition, we found the upregulated expression of BCL‐2 in senescent T‐cell malignancies because of the antiapoptotic properties of senescent cells. Following up this result, we identified a BCL‐2 inhibitor Navitoclax (ABT‐263), which was highly effective in decreasing cell viability and inducing apoptotic cell death in wogonin‐induced senescent cells. Thus, the “one‐two punch” approach increased the sensibility of T‐cell malignancies with low expression of BCL‐2 to Navitoclax. In conclusion, our research revealed that wogonin possesses potential antitumor effects based on senescence induction, offering a better insight into the development of novel therapeutic methods for T‐cell malignancies.


  • Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition

    by Xiaoxuan Yu, Hui Li, Mengyuan Zhu, Po Hu, Xiao Liu, Yingjie Qing, Xiangyuan Wang, Hongzheng Wang, Zhanyu Wang, Jingyan Xu, et al.


  • Maximum flow and network capacity of network coding for ad-hoc networks

    by Hongzheng Wang, Pingyi Fan, Khaled Letaief

    Network coding is an effective way to achieve the maximum flow of multicast networks. In this letter, we focus on the statistical properties of the maximum flow or the capacity of network coding for ad-hoc networks based on random graph models. Theoretical analysis shows that the maximum flow can be modelled as extreme order statistics of Gaussian distribution for both wired and wireless ad-hoc networks as the node number is relatively large under a certain condition. We also investigate the effects of the nodes' covering capabilities on the capacity of network coding.